World's Best Scientists 2026 revealed!
Huldrych F. Günthard

Huldrych F. Günthard

Award Badge
Immunology
Switzerland
2026
Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Immunology

D-Index
108
Citations
49626
World Ranking
530
National Ranking
11

Medicine

D-Index
108
Citations
49626
World Ranking
5942
National Ranking
77

Research.com Recognitions

  • 2026 - Research.com Immunology in Switzerland Leader Award
  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Huldrych F. Günthard is affiliated with the University of Zurich in Switzerland and has a substantial publication record focused primarily on infectious diseases, immunology, and microbiology. Their work spans various subfields including infectious diseases, virology, epidemiology, emergency medicine, and hepatology.

The scientist's research topics prominently feature HIV research and treatment, HIV/AIDS drug development and treatment, and HIV/AIDS research and interventions. Additionally, they have contributed to studies on HIV-related health complications and treatments, COVID-19 clinical research studies, hepatitis C virus research, and SARS-CoV-2 and COVID-19 research.

Frequent co-authors include:

  • Roger D. Kouyos
  • Enos Bernasconi
  • Dominique L. Braun
  • Matthias Cavassini
  • Alexandra Calmy

Publication venues where Huldrych F. Günthard has frequently contributed are:

  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • JAIDS Journal of Acquired Immune Deficiency Syndromes

Some selected recent papers from their research portfolio include:

  • "Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults," 2022, JAMA
  • "Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults," 2020, JAMA
  • "2025 update of the drug resistance mutations in HIV-1," 2025, PubMed
  • "Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)," 2021, International Journal of Epidemiology
  • "Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium," 2022, The Lancet HIV

With a total of 490 publications related to medicine and 136 in immunology and microbiology, Huldrych F. Günthard's output reflects a strong focus on clinical and epidemiological aspects of infectious diseases, particularly in the context of HIV/AIDS. Their collaborative network and choice of publication venues suggest active participation in both clinical research and public health-oriented studies.

Best Publications

  • Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

    Joseph K. Wong;Marjan Hezareh;Huldrych F. Günthard;Diane V. Havlir

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Update of the Drug Resistance Mutations in HIV-1.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

    Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai

  • 2011 update of the drug resistance mutations in HIV-1.

    Johnson Va;Calvez;Günthard Hf;Paredes R

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • 2017 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • 2014 Update of the drug resistance mutations in HIV-1.

    Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • 2015 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

    Alexandra Trkola;Herbert Kuster;Peter Rusert;Beda Joos

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • 2019 update of the drug resistance mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Francesca Ceccherini-Silberstein;Charlotte Charpentier

  • Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Cohort profile: the Swiss HIV Cohort study

    Franziska Schoeni-Affolter;Bruno Ledergerber;Martin Rickenbach;Christoph Rudin

  • Prevalence and predictive value of intermittent viremia with combination hiv therapy.

    Diane V. Havlir;Roland Bassett;Diane Levitan;Peter Gilbert

  • Common genetic variation and the control of HIV-1 in humans.

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

    Michael S. Saag;Rajesh T. Gandhi;Jennifer F. Hoy;Raphael J. Landovitz

  • Common Genetic Variation and the Control of HIV-1 in Humans

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

Frequent Co-Authors

Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Roger D. Kouyos
Roger D. Kouyos University of Zurich
Matthias Cavassini
Matthias Cavassini University of Lausanne
Jürg Böni
Jürg Böni University of Zurich
Sabine Yerly
Sabine Yerly University of Geneva
Manuel Battegay
Manuel Battegay University Hospital of Basel
Andri Rauch
Andri Rauch University of Bern
Hansjakob Furrer
Hansjakob Furrer University of Bern
Thomas Klimkait
Thomas Klimkait University of Basel
Pietro Vernazza
Pietro Vernazza University of St. Gallen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens diverse opportunities that often intersect with nursing and healthcare fields. For those interested in advancing their clinical expertise, obtaining an acute care NP certification can be a vital step. This certification allows nurse practitioners to work in high-intensity settings, managing complex immunological conditions and critical care patients.

For individuals aiming to fast-track their nursing careers alongside immunology, exploring an accelerated FNP program offers a rigorous yet efficient pathway to becoming a Family Nurse Practitioner. Such programs emphasize clinical skills beneficial for immunology-related healthcare roles.

Non-nurses interested in entering the nursing field and contributing to immunology research or clinical practice can consider online RN programs for non nurses in Florida. These programs provide a flexible route to earn a nursing license while building foundational medical knowledge applicable to immunology careers.

Lastly, aspiring nurses looking for accessible entry points into nursing can benefit from ABSN programs with high acceptance rates. These programs often cater to students seeking a quicker transition into the nursing profession, which can complement immunology studies with practical patient care experience.

Best Scientists Citing Huldrych F. Günthard

Trending Scientists

Recently Published Articles